Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - venlafaxine hydrochloride, quantity: 42.45 mg (equivalent: venlafaxine, qty 37.5 mg) - capsule, modified release - excipient ingredients: iron oxide black; ethylcellulose; colloidal anhydrous silica; copovidone; titanium dioxide; magnesium stearate; povidone; gelatin; microcrystalline cellulose; purified talc; iron oxide red; iron oxide yellow; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; ethanol absolute; ammonia - venlafaxine medis xr is indicated for the treatment of: - major depression, including prevention of relapse and recurrence where appropriate; - generalised anxiety disorder; - social anxiety disorder; panic disorder, including prevention of relapse.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - quetiapine fumarate -

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - oxycodone hydrochloride, quantity: 10 mg - capsule, hard - excipient ingredients: gelatin; microcrystalline cellulose; indigo carmine; magnesium stearate; iron oxide yellow; titanium dioxide; iron oxide red; sodium laureth sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - oxycodone medis is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - oxycodone hydrochloride, quantity: 10 mg - capsule, hard - excipient ingredients: gelatin; titanium dioxide; iron oxide red; indigo carmine; magnesium stearate; iron oxide yellow; microcrystalline cellulose; sodium laureth sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - oxycodone medis is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - oxycodone hydrochloride, quantity: 5 mg - capsule, hard - excipient ingredients: gelatin; sodium laureth sulfate; indigo carmine; iron oxide yellow; iron oxide red; microcrystalline cellulose; titanium dioxide; magnesium stearate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - oxycodone medis is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - oxycodone hydrochloride, quantity: 5 mg - capsule, hard - excipient ingredients: sodium laureth sulfate; iron oxide red; gelatin; microcrystalline cellulose; titanium dioxide; iron oxide yellow; indigo carmine; magnesium stearate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - oxycodone medis is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - oxycodone hydrochloride, quantity: 20 mg - capsule, hard - excipient ingredients: gelatin; iron oxide red; magnesium stearate; titanium dioxide; indigo carmine; microcrystalline cellulose; iron oxide yellow; sodium laureth sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - oxycodone medis is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - oxycodone hydrochloride, quantity: 20 mg - capsule, hard - excipient ingredients: microcrystalline cellulose; sodium laureth sulfate; gelatin; titanium dioxide; iron oxide red; indigo carmine; iron oxide yellow; magnesium stearate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - oxycodone medis is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - quetiapine fumarate -

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - quetiapine fumarate -